Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma
Clinical trial NCT03604978 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03604978
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-17
- Primary completion
- 2027-03-19
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.